Skip to main content

Ongoing FDAEvent 98509 (3 months ago)

TMJ Solutions Bilateral Implants

Custom temporomandibular joint implant may have contained incorrect patient-specific components, leading to a poor fit and a right-sided open bite.

Moderate risk

Using it may cause temporary or medically reversible health problems. Serious harm is unlikely.

FDA Class II recall · How risk is rated

What to do

What happened

TMJ Solutions Inc, of Ventura, California, began a recall of TMJ Bilateral Implants, REF: CHG020, on February 11, 2026. The FDA added the recall to its Enforcement Report and classified it on June 22, 2026, and the recall was in the FDA's weekly enforcement report on July 1, 2026. The custom temporomandibular joint implant may have contained incorrect patient-specific components that led to a poor fit, leading to a right-sided open bite. Distribution was in Massachusetts.

Summary by Recall Canary from the FDA notice.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the UDI-DI and reference number listed under your product.

  1. TMJ Bilateral Implants

    UDI-DI
    • 07613327626575
    • 2508181038
    Reference number
    • CHG020

Details

Company began the recall
Sold in

US Nationwide distribution in the state of Massachusetts.

Event ID
98509
Recall No.
Z-2524-2026
Company
TMJ Solutions IncVentura, California
Recall type
Voluntary: Firm initiated
Customers told by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration